Pharmaceutical Commerce - October 2024

Click the title above for a link to open the Pharmaceutical Commerce October 2024 issue in an interactive PDF format.

Headlining our October issue of Pharmaceutical Commerce is a look inside an emerging key component of cold chain transport and management—ensuring the safety and control of novel injectable drugs through to their "last mile."

Getting a handle on level of compliance-readiness for the Drug Supply Chain Security Act deadline—now just weeks away.

The Healthcare Distribution Alliance's latest seminar was as timely as ever, with the end of the stabilization period for DSCSA implementation drawing closer.

Why it's critical for companies to set long-term, strategic goals in their journeys toward decarbonization.

When it comes to navigating the complex clinical and commercial landscape for specialty drugs—including hurdles in access to these critical but costly therapies—today’s specialty pharmacies are bringing more skills and services to the table.

Various forms of technology—including in the serialization and refrigeration spaces—are necessary in order to keep goods flowing smoothly through the supply chain.

Alongside the proper temperature-monitoring technology, optimal production control is necessary for success in cold chain drug delivery.

How can buyers maximize the value of their acquisitions?

Why looming benefit changes—and the resulting unintended consequences—are a concern for patients.

As the dust settles on the first round of Medicare negotiations, not everything is what it seems.

Why this trend is occurring and ways that drugmakers are pivoting in order to remedy the situation.